Naik Bukke V, Archana M, Villani R, Serviddio G, Cassano T
Pharmaceuticals (Basel). 2021; 14(10).
PMID: 34681189
PMC: 8541640.
DOI: 10.3390/ph14100965.
Shafi A, Berry A, Sumnall H, Wood D, Tracy D
Ther Adv Psychopharmacol. 2021; 10:2045125320967197.
PMID: 33414905
PMC: 7750892.
DOI: 10.1177/2045125320967197.
Neicun J, Steenhuizen M, van Kessel R, Yang J, Negri A, Czabanowska K
PLoS One. 2019; 14(6):e0218011.
PMID: 31242225
PMC: 6594604.
DOI: 10.1371/journal.pone.0218011.
Gamage T, Farquhar C, McKinnie R, Kevin R, McGregor I, Trudell M
J Pharmacol Exp Ther. 2018; 368(3):414-422.
PMID: 30552295
PMC: 6374541.
DOI: 10.1124/jpet.118.254425.
Theunissen E, Hutten N, Mason N, Toennes S, Kuypers K, de Sousa Fernandes Perna E
Br J Pharmacol. 2017; 175(1):18-28.
PMID: 29164599
PMC: 5740243.
DOI: 10.1111/bph.14066.
Identifying Complementary and Alternative Medicine Usage Information from Internet Resources. A Systematic Review.
Sharma V, Holmes J, Sarkar I
Methods Inf Med. 2016; 55(4):322-32.
PMID: 27352304
PMC: 4975632.
DOI: 10.3414/ME15-01-0154.
K2 and Spice use among a cohort of college students in southeast region of the USA.
Egan K, Suerken C, Reboussin B, Spangler J, Wagoner K, Sutfin E
Am J Drug Alcohol Abuse. 2015; 41(4):317-22.
PMID: 26030768
PMC: 4526379.
DOI: 10.3109/00952990.2015.1043438.
Validation of an ELISA Synthetic Cannabinoids Urine Assay.
Barnes A, Spinelli E, Young S, Martin T, Kleete K, Huestis M
Ther Drug Monit. 2015; 37(5):661-9.
PMID: 25706046
PMC: 4544679.
DOI: 10.1097/FTD.0000000000000201.
Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals.
Hohmann N, Mikus G, Czock D
Dtsch Arztebl Int. 2014; 111(9):139-47.
PMID: 24661585
PMC: 3965957.
DOI: 10.3238/arztebl.2014.0139.
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum.
Kjellgren A, Henningsson H, Soussan C
Subst Abuse. 2013; 7:191-8.
PMID: 24324336
PMC: 3855086.
DOI: 10.4137/SART.S13323.
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?.
Fantegrossi W, Moran J, Radominska-Pandya A, Prather P
Life Sci. 2013; 97(1):45-54.
PMID: 24084047
PMC: 3945037.
DOI: 10.1016/j.lfs.2013.09.017.
The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
Brents L, Prather P
Drug Metab Rev. 2013; 46(1):72-85.
PMID: 24063277
PMC: 4100246.
DOI: 10.3109/03602532.2013.839700.
Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.
Cox A, Daw R, Mason M, Grabenauer M, Pande P, Davis K
J Anal Toxicol. 2012; 36(5):293-302.
PMID: 22582264
PMC: 3611872.
DOI: 10.1093/jat/bks025.
European dimension of cannabinoid-like products use.
Surugiu M, Minca D
J Med Life. 2012; 5(1):79-81.
PMID: 22574091
PMC: 3307084.
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
Seely K, Lapoint J, Moran J, Fattore L
Prog Neuropsychopharmacol Biol Psychiatry. 2012; 39(2):234-43.
PMID: 22561602
PMC: 3936256.
DOI: 10.1016/j.pnpbp.2012.04.017.
Beyond THC: The New Generation of Cannabinoid Designer Drugs.
Fattore L, Fratta W
Front Behav Neurosci. 2011; 5:60.
PMID: 22007163
PMC: 3187647.
DOI: 10.3389/fnbeh.2011.00060.
CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists.
Atwood B, Lee D, Straiker A, Widlanski T, Mackie K
Eur J Pharmacol. 2011; 659(2-3):139-45.
PMID: 21333643
PMC: 3094488.
DOI: 10.1016/j.ejphar.2011.01.066.
